Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet di...
Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease
About this item
Full title
Author / Creator
Publisher
BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
AimTo compare the efficacy and safety of infliximab versus ciclosporin A (CsA) in refractory uveoretinitis in Behçet disease.MethodsIn this retrospective clinical chart review of patients with Behçet disease who were treated with CsA or infliximab, we collected information on the number of uveitis attacks, visual acuity and adverse side effects tha...
Alternative Titles
Full title
Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1778932087
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1778932087
Other Identifiers
ISSN
0007-1161
E-ISSN
1468-2079
DOI
10.1136/bjo.2009.158840
